We are live on ! Find out more
EAM

Erste Asset Management Portfolio holdings

AUM $12.9B
1-Year Est. Return 52.69%
This Fund
S&P 500
This Quarter Est. Return
+4.69%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
AUM
$7.55B
AUM Growth
+$207M
Cap. Flow
+$12.8M
Cap. Flow %
0.17%
Top 10 Hldgs %
25.66%
Holding
574
New
32
Increased
147
Reduced
149
Closed
28

Top Buys

Rank Stock Value
1
PGR icon
Progressive
PGR
+$58.2M
2
AAPL icon
Apple
AAPL
+$27.2M
3
LLY icon
Eli Lilly
LLY
+$24.1M
4
ANET icon
Arista Networks
ANET
+$9.78M
5
BLMN icon
Bloomin' Brands
BLMN
+$9.38M

Top Sells

Rank Stock Value
1
NUE icon
Nucor
NUE
+$50.9M
2
NVDA icon
NVIDIA
NVDA
+$37.6M
3
AMAT icon
Applied Materials
AMAT
+$13M
4
COST icon
Costco
COST
+$11.9M
5
GNRC icon
Generac Holdings
GNRC
+$10.4M

Sector Composition

Rank Sector Weight
1 Technology 35.83%
2 Healthcare 16.89%
3 Financials 10.88%
4 Consumer Discretionary 9.28%
5 Communication Services 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PICK icon
451
iShares MSCI Global Metals & Mining Producers ETF
PICK
$2.22B
$280K ﹤0.01%
6,850
UNFI icon
452
United Natural Foods
UNFI
$3.08B
$273K ﹤0.01%
21,144
-5,000
-19% -$56.2K
IOVA icon
453
Iovance Biotherapeutics
IOVA
$1.82B
$272K ﹤0.01%
34,000
RDN icon
454
Radian Group
RDN
$5.18B
$271K ﹤0.01%
8,800
CINF icon
455
Cincinnati Financial
CINF
$27.3B
$268K ﹤0.01%
2,300
EXPE icon
456
Expedia Group
EXPE
$35.4B
$267K ﹤0.01%
+2,100
New +$259K
ZLAB icon
457
Zai Lab
ZLAB
$2.06B
$265K ﹤0.01%
15,100
GL icon
458
Globe Life
GL
$14.2B
$263K ﹤0.01%
3,200
NTAP icon
459
NetApp
NTAP
$35B
$257K ﹤0.01%
+2,000
New +$225K
VIR icon
460
Vir Biotechnology
VIR
$1.46B
$255K ﹤0.01%
28,800
RXRX icon
461
Recursion Pharmaceuticals
RXRX
$1.59B
$254K ﹤0.01%
33,500
MDB icon
462
MongoDB
MDB
$27.1B
$251K ﹤0.01%
1,030
-270
-21% -$85.3K
DVA icon
463
DaVita
DVA
$15.4B
$249K ﹤0.01%
+1,750
New +$241K
LII icon
464
Lennox International
LII
$14.4B
$246K ﹤0.01%
+460
New +$227K
ARE icon
465
Alexandria Real Estate Equities
ARE
$8.97B
$246K ﹤0.01%
2,100
-300
-13% -$35.8K
BCRX icon
466
BioCryst Pharmaceuticals
BCRX
$2.28B
$244K ﹤0.01%
40,000
APA icon
467
APA Corp
APA
$13.2B
$243K ﹤0.01%
+8,500
New +$263K
PHM icon
468
Pultegroup
PHM
$24.1B
$242K ﹤0.01%
+2,200
New +$250K
IR icon
469
Ingersoll Rand
IR
$32.6B
$233K ﹤0.01%
+2,600
New +$239K
TSCO icon
470
Tractor Supply
TSCO
$16.1B
$227K ﹤0.01%
+4,250
New +$228K
AFG icon
471
American Financial Group
AFG
$11.8B
$226K ﹤0.01%
1,800
KURA icon
472
Kura Oncology
KURA
$800M
$226K ﹤0.01%
11,000
SANA icon
473
Sana Biotechnology
SANA
$871M
$216K ﹤0.01%
40,000
SBAC icon
474
SBA Communications
SBAC
$19.2B
$216K ﹤0.01%
+1,100
New +$218K
MRVI icon
475
Maravai LifeSciences
MRVI
$969M
$201K ﹤0.01%
28,400

Similar funds

Erste Asset Management's Q2 2024 Portfolio in Review

As of Q2 2024, Erste Asset Management held 574 positions worth $7.55B, up 2.8% from $7.34B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Erste Asset Management's Q2 2024 filing shows 32 new, 147 increased, 149 reduced and 28 closed positions. Its largest new stake was Zillow: 200,000 shares worth $9.36M. The largest sale was Nucor, an estimated $50.9M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 34% a quarter earlier, followed by Healthcare and Financials.

  • Erste Asset Management's largest Q2 2024 buy was Zillow: 200,000 shares worth $9.36M.
  • Erste Asset Management added most to Progressive in Q2 2024, an estimated $58.2M increase.
  • Erste Asset Management's biggest Q2 2024 reduction was Nucor, cutting an estimated $50.9M.
  • Erste Asset Management fully exited Fomento Económico Mexicano in Q2 2024, selling an estimated $8.44M.
  • Erste Asset Management's ten largest holdings make up 26% of its $7.55B portfolio in Q2 2024.
  • Erste Asset Management opened 32 new positions and closed 28 in Q2 2024.
  • Erste Asset Management's portfolio value rose 2.8% quarter-over-quarter to $7.55B.

Based on Erste Asset Management's 13F filing for Q2 2024, filed 26 Nov 2024.